Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-03

Clinical Trial Update: Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluating riboflavin for reducing muscle soreness in ultra-marathon athletes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riboflavin (riboflavin)

Snippet

Sponsor: Steven Moore | Conditions: Muscle Soreness | EARLY_Phase 1 | Status: COMPLETED